Copyright Reports & Markets. All rights reserved.

Global Oncology Drug Discovery Services Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Oncology Drug Discovery Services Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Identification Service
    • 1.3.3 Authentication Service
    • 1.3.4 Hit-to-lead and Lead Optimization Services
    • 1.3.5 Others
  • 1.4 Market by Application
    • 1.4.1 Global Oncology Drug Discovery Services Market Share by Application: 2020 VS 2026
    • 1.4.2 Research Institutes
    • 1.4.3 Pharmaceutical Companies
    • 1.4.4 Biotechnology Companies
    • 1.4.5 Others
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Oncology Drug Discovery Services Market Perspective (2015-2026)
  • 2.2 Oncology Drug Discovery Services Growth Trends by Regions
    • 2.2.1 Oncology Drug Discovery Services Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Oncology Drug Discovery Services Historic Market Share by Regions (2015-2020)
    • 2.2.3 Oncology Drug Discovery Services Forecasted Market Size by Regions (2021-2026)
  • 2.3 Oncology Drug Discovery Services Industry Dynamic
    • 2.3.1 Oncology Drug Discovery Services Market Trends
    • 2.3.2 Oncology Drug Discovery Services Market Drivers
    • 2.3.3 Oncology Drug Discovery Services Market Challenges
    • 2.3.4 Oncology Drug Discovery Services Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Oncology Drug Discovery Services Players by Market Size
    • 3.1.1 Global Top Oncology Drug Discovery Services Players by Revenue (2015-2020)
    • 3.1.2 Global Oncology Drug Discovery Services Revenue Market Share by Players (2015-2020)
  • 3.2 Global Oncology Drug Discovery Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Oncology Drug Discovery Services Revenue
  • 3.4 Global Oncology Drug Discovery Services Market Concentration Ratio
    • 3.4.1 Global Oncology Drug Discovery Services Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Oncology Drug Discovery Services Revenue in 2019
  • 3.5 Key Players Oncology Drug Discovery Services Area Served
  • 3.6 Key Players Oncology Drug Discovery Services Product Solution and Service
  • 3.7 Date of Enter into Oncology Drug Discovery Services Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Drug Discovery Services Breakdown Data by Type

  • 4.1 Global Oncology Drug Discovery Services Historic Market Size by Type (2015-2020)
  • 4.2 Global Oncology Drug Discovery Services Forecasted Market Size by Type (2021-2026)

5 Oncology Drug Discovery Services Breakdown Data by Application

  • 5.1 Global Oncology Drug Discovery Services Historic Market Size by Application (2015-2020)
  • 5.2 Global Oncology Drug Discovery Services Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Oncology Drug Discovery Services Market Size (2015-2026)
  • 6.2 North America Oncology Drug Discovery Services Market Size by Type (2015-2020)
  • 6.3 North America Oncology Drug Discovery Services Market Size by Application (2015-2020)
  • 6.4 North America Oncology Drug Discovery Services Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Oncology Drug Discovery Services Market Size (2015-2026)
  • 7.2 Europe Oncology Drug Discovery Services Market Size by Type (2015-2020)
  • 7.3 Europe Oncology Drug Discovery Services Market Size by Application (2015-2020)
  • 7.4 Europe Oncology Drug Discovery Services Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Oncology Drug Discovery Services Market Size (2015-2026)
  • 8.2 Asia-Pacific Oncology Drug Discovery Services Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Oncology Drug Discovery Services Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Oncology Drug Discovery Services Market Size (2015-2026)
  • 9.2 Latin America Oncology Drug Discovery Services Market Size by Type (2015-2020)
  • 9.3 Latin America Oncology Drug Discovery Services Market Size by Application (2015-2020)
  • 9.4 Latin America Oncology Drug Discovery Services Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Oncology Drug Discovery Services Market Size (2015-2026)
  • 10.2 Middle East & Africa Oncology Drug Discovery Services Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Oncology Drug Discovery Services Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Charles River
    • 11.1.1 Charles River Company Details
    • 11.1.2 Charles River Business Overview
    • 11.1.3 Charles River Oncology Drug Discovery Services Introduction
    • 11.1.4 Charles River Revenue in Oncology Drug Discovery Services Business (2015-2020))
    • 11.1.5 Charles River Recent Development
  • 11.2 Evotec
    • 11.2.1 Evotec Company Details
    • 11.2.2 Evotec Business Overview
    • 11.2.3 Evotec Oncology Drug Discovery Services Introduction
    • 11.2.4 Evotec Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 11.2.5 Evotec Recent Development
  • 11.3 GE Healthcare Life Sciences
    • 11.3.1 GE Healthcare Life Sciences Company Details
    • 11.3.2 GE Healthcare Life Sciences Business Overview
    • 11.3.3 GE Healthcare Life Sciences Oncology Drug Discovery Services Introduction
    • 11.3.4 GE Healthcare Life Sciences Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 11.3.5 GE Healthcare Life Sciences Recent Development
  • 11.4 GenScript
    • 11.4.1 GenScript Company Details
    • 11.4.2 GenScript Business Overview
    • 11.4.3 GenScript Oncology Drug Discovery Services Introduction
    • 11.4.4 GenScript Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 11.4.5 GenScript Recent Development
  • 11.5 Horizon Discovery
    • 11.5.1 Horizon Discovery Company Details
    • 11.5.2 Horizon Discovery Business Overview
    • 11.5.3 Horizon Discovery Oncology Drug Discovery Services Introduction
    • 11.5.4 Horizon Discovery Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 11.5.5 Horizon Discovery Recent Development
  • 11.6 TCG Lifesciences
    • 11.6.1 TCG Lifesciences Company Details
    • 11.6.2 TCG Lifesciences Business Overview
    • 11.6.3 TCG Lifesciences Oncology Drug Discovery Services Introduction
    • 11.6.4 TCG Lifesciences Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 11.6.5 TCG Lifesciences Recent Development
  • 11.7 Zumutor
    • 11.7.1 Zumutor Company Details
    • 11.7.2 Zumutor Business Overview
    • 11.7.3 Zumutor Oncology Drug Discovery Services Introduction
    • 11.7.4 Zumutor Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 11.7.5 Zumutor Recent Development
  • 11.8 ChemPartner
    • 11.8.1 ChemPartner Company Details
    • 11.8.2 ChemPartner Business Overview
    • 11.8.3 ChemPartner Oncology Drug Discovery Services Introduction
    • 11.8.4 ChemPartner Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 11.8.5 ChemPartner Recent Development
  • 11.9 Aquila BioMedical
    • 11.9.1 Aquila BioMedical Company Details
    • 11.9.2 Aquila BioMedical Business Overview
    • 11.9.3 Aquila BioMedical Oncology Drug Discovery Services Introduction
    • 11.9.4 Aquila BioMedical Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 11.9.5 Aquila BioMedical Recent Development
  • 11.10 Onconova
    • 11.10.1 Onconova Company Details
    • 11.10.2 Onconova Business Overview
    • 11.10.3 Onconova Oncology Drug Discovery Services Introduction
    • 11.10.4 Onconova Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 11.10.5 Onconova Recent Development
  • 11.11 Vichem Chemie
    • 10.11.1 Vichem Chemie Company Details
    • 10.11.2 Vichem Chemie Business Overview
    • 10.11.3 Vichem Chemie Oncology Drug Discovery Services Introduction
    • 10.11.4 Vichem Chemie Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 10.11.5 Vichem Chemie Recent Development
  • 11.12 GVK Biosciences
    • 10.12.1 GVK Biosciences Company Details
    • 10.12.2 GVK Biosciences Business Overview
    • 10.12.3 GVK Biosciences Oncology Drug Discovery Services Introduction
    • 10.12.4 GVK Biosciences Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 10.12.5 GVK Biosciences Recent Development
  • 11.13 NuChem Therapeutics
    • 10.13.1 NuChem Therapeutics Company Details
    • 10.13.2 NuChem Therapeutics Business Overview
    • 10.13.3 NuChem Therapeutics Oncology Drug Discovery Services Introduction
    • 10.13.4 NuChem Therapeutics Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 10.13.5 NuChem Therapeutics Recent Development
  • 11.14 Syncom
    • 10.14.1 Syncom Company Details
    • 10.14.2 Syncom Business Overview
    • 10.14.3 Syncom Oncology Drug Discovery Services Introduction
    • 10.14.4 Syncom Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 10.14.5 Syncom Recent Development
  • 11.15 Envigo
    • 10.15.1 Envigo Company Details
    • 10.15.2 Envigo Business Overview
    • 10.15.3 Envigo Oncology Drug Discovery Services Introduction
    • 10.15.4 Envigo Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 10.15.5 Envigo Recent Development
  • 11.16 DiverChim
    • 10.16.1 DiverChim Company Details
    • 10.16.2 DiverChim Business Overview
    • 10.16.3 DiverChim Oncology Drug Discovery Services Introduction
    • 10.16.4 DiverChim Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 10.16.5 DiverChim Recent Development
  • 11.17 Aurora
    • 10.17.1 Aurora Company Details
    • 10.17.2 Aurora Business Overview
    • 10.17.3 Aurora Oncology Drug Discovery Services Introduction
    • 10.17.4 Aurora Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 10.17.5 Aurora Recent Development
  • 11.18 HD Biosciences
    • 10.18.1 HD Biosciences Company Details
    • 10.18.2 HD Biosciences Business Overview
    • 10.18.3 HD Biosciences Oncology Drug Discovery Services Introduction
    • 10.18.4 HD Biosciences Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 10.18.5 HD Biosciences Recent Development
  • 11.19 WuXi AppTec
    • 10.19.1 WuXi AppTec Company Details
    • 10.19.2 WuXi AppTec Business Overview
    • 10.19.3 WuXi AppTec Oncology Drug Discovery Services Introduction
    • 10.19.4 WuXi AppTec Revenue in Oncology Drug Discovery Services Business (2015-2020)
    • 10.19.5 WuXi AppTec Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Oncology Drug Discovery Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Drug Discovery Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Identification Service
    Authentication Service
    Hit-to-lead and Lead Optimization Services
    Others

    Market segment by Application, split into
    Research Institutes
    Pharmaceutical Companies
    Biotechnology Companies
    Others

    Based on regional and country-level analysis, the Oncology Drug Discovery Services market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Oncology Drug Discovery Services market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Charles River
    Evotec
    GE Healthcare Life Sciences
    GenScript
    Horizon Discovery
    TCG Lifesciences
    Zumutor
    ChemPartner
    Aquila BioMedical
    Onconova
    Vichem Chemie
    GVK Biosciences
    NuChem Therapeutics
    Syncom
    Envigo
    DiverChim
    Aurora
    HD Biosciences

    Buy now